Systemic zoledronate treatment both prevents resorption of allograft bone and increases the retention of new formed bone during revascularization and remodelling. A bone chamber study in rats

Peer Review reports

Original Submission
13 Mar 2006	Submitted	Original manuscript
15 Apr 2006	Reviewed	Reviewer Report - Brigitte Rechenberg
20 Apr 2006	Reviewed	Reviewer Report - Dominique Pioletti
3 Jun 2006	Author responded	Author comments - Magnus Tägil
Resubmission - Version 2
3 Jun 2006	Submitted	Manuscript version 2
23 Jun 2006	Reviewed	Reviewer Report - Dominique Pioletti
3 Jul 2006	Reviewed	Reviewer Report - Brigitte Rechenberg
1 Aug 2006	Author responded	Author comments - Magnus Tägil
Resubmission - Version 3
1 Aug 2006	Submitted	Manuscript version 3
Publishing
4 Aug 2006	Editorially accepted
4 Aug 2006	Article published	10.1186/1471-2474-7-63

Back to article page